Presentation + Paper
14 March 2023 A new candidate agent for fluorescence-guided neurosurgery produces high, persistent tumor contrast shortly after administration
Author Affiliations +
Abstract
Neurosurgical fluorescence guidance relies on contrast agents to identify tumor regions to aid in increasing the extent of resection. Existing contrast agents for this indication each have their own limitation: unpredictable contrast from tumor heterogeneity, significant extravasation into the background brain and long incubation times. An ideal contrast agent should have high and rapid contrast that persists well into the surgical procedure. By using a whole animal hyperspectral cryo-imaging system several CAs were screened for these favorable properties and compared to the gold standard of gadolinium enhanced MR. Herein, we briefly report on the leading candidate Rd-PEG1k, which shows high contrast within minutes of administration that persists for at least 90 minutes.
Conference Presentation
© (2023) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Augustino V. Scorzo, Brook K. Byrd, Rendall R. Strawbridge, and Scott C. Davis "A new candidate agent for fluorescence-guided neurosurgery produces high, persistent tumor contrast shortly after administration", Proc. SPIE 12361, Molecular-Guided Surgery: Molecules, Devices, and Applications IX, 1236106 (14 March 2023); https://doi.org/10.1117/12.2650599
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Tumors

Fluorescence

Gadolinium

Brain

Contrast agents

Resection

Magnetic resonance imaging

Back to Top